LENSAR Investor Relations Material

LENSAR, Inc. is a commercial-stage medical device company focused on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. The company designed their first product for use in cataract surgery, which enables physicians to deliver superior results faster and more cost effectively than current standard-of-care. LENSAR's proprietary femtosecond laser technology enables precise tissue cutting in as little as one tenth of a second to create clear, void-free wounds in corneal muscles that facilitate insertion of intraocular lens implants.